| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3659901
[patent_doc_number] => 05648267
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-15
[patent_title] => 'Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same'
[patent_app_type] => 1
[patent_app_number] => 8/147696
[patent_app_country] => US
[patent_app_date] => 1993-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 16952
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/648/05648267.pdf
[firstpage_image] =>[orig_patent_app_number] => 147696
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/147696 | Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same | Nov 2, 1993 | Issued |
Array
(
[id] => 3723051
[patent_doc_number] => 05681737
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-28
[patent_title] => 'Detection system for mutagens that also identifies mutagenic changes'
[patent_app_type] => 1
[patent_app_number] => 8/137627
[patent_app_country] => US
[patent_app_date] => 1993-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 22
[patent_no_of_words] => 26211
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/681/05681737.pdf
[firstpage_image] =>[orig_patent_app_number] => 137627
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/137627 | Detection system for mutagens that also identifies mutagenic changes | Oct 14, 1993 | Issued |
Array
(
[id] => 3612272
[patent_doc_number] => 05534423
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-09
[patent_title] => 'Methods of increasing rates of infection by directing motion of vectors'
[patent_app_type] => 1
[patent_app_number] => 8/134105
[patent_app_country] => US
[patent_app_date] => 1993-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5146
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/534/05534423.pdf
[firstpage_image] =>[orig_patent_app_number] => 134105
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/134105 | Methods of increasing rates of infection by directing motion of vectors | Oct 7, 1993 | Issued |
Array
(
[id] => 3548933
[patent_doc_number] => 05545726
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-13
[patent_title] => 'Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits'
[patent_app_type] => 1
[patent_app_number] => 8/132919
[patent_app_country] => US
[patent_app_date] => 1993-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 6913
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/545/05545726.pdf
[firstpage_image] =>[orig_patent_app_number] => 132919
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/132919 | Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits | Oct 6, 1993 | Issued |
| 08/119609 | TRANSFORMATION OF PHAFFIA RHODOZYMA | Sep 9, 1993 | Abandoned |
Array
(
[id] => 3827460
[patent_doc_number] => 05739007
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-14
[patent_title] => 'Hybrid GAL10/pgk yeast promoter'
[patent_app_type] => 1
[patent_app_number] => 8/119926
[patent_app_country] => US
[patent_app_date] => 1993-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4127
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/739/05739007.pdf
[firstpage_image] =>[orig_patent_app_number] => 119926
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/119926 | Hybrid GAL10/pgk yeast promoter | Sep 9, 1993 | Issued |
Array
(
[id] => 1532146
[patent_doc_number] => 06410322
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Antisense oligonucleotide inhibition of vascular endothelial growth factor expression'
[patent_app_type] => B1
[patent_app_number] => 08/098942
[patent_app_country] => US
[patent_app_date] => 1993-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6802
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410322.pdf
[firstpage_image] =>[orig_patent_app_number] => 08098942
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/098942 | Antisense oligonucleotide inhibition of vascular endothelial growth factor expression | Jul 26, 1993 | Issued |
Array
(
[id] => 3693631
[patent_doc_number] => 05650319
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-22
[patent_title] => 'Human monoclonal antibody to glycoprotein GPIII of varicella zoster virus'
[patent_app_type] => 1
[patent_app_number] => 8/089616
[patent_app_country] => US
[patent_app_date] => 1993-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 7871
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/650/05650319.pdf
[firstpage_image] =>[orig_patent_app_number] => 089616
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/089616 | Human monoclonal antibody to glycoprotein GPIII of varicella zoster virus | Jul 11, 1993 | Issued |
| 08/087119 | TATA-BINDING PROTEIN ASSOCIATED FACTORS, NUCLEIC ACIDS ENCODING TAFS, AND METHODS OF USE | Jun 29, 1993 | Pending |
| 08/084893 | METHOD AND MEANS FOR THE PRODUCTION OF GENE PRODUCTS | Jun 28, 1993 | Pending |
Array
(
[id] => 3582766
[patent_doc_number] => 05498696
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-03-12
[patent_title] => 'Sterol regulatory element binding proteins and their use in screening assays'
[patent_app_type] => 1
[patent_app_number] => 8/061697
[patent_app_country] => US
[patent_app_date] => 1993-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 25
[patent_no_of_words] => 24881
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/498/05498696.pdf
[firstpage_image] =>[orig_patent_app_number] => 061697
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/061697 | Sterol regulatory element binding proteins and their use in screening assays | May 12, 1993 | Issued |
Array
(
[id] => 3766964
[patent_doc_number] => 05849500
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Phagemid for antibody screening'
[patent_app_type] => 1
[patent_app_number] => 7/982743
[patent_app_country] => US
[patent_app_date] => 1993-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 5009
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849500.pdf
[firstpage_image] =>[orig_patent_app_number] => 982743
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/982743 | Phagemid for antibody screening | May 9, 1993 | Issued |
| 08/013412 | TATA-BINDING PROTEIN ASSOCIATED FACTORS, NUCLEIC ACIDS ENCODING TAFS, AND METHODS OF USE | Jan 27, 1993 | Abandoned |
Array
(
[id] => 4403347
[patent_doc_number] => 06270988
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'Process for producing recombinant proteins using a gene for tRNA'
[patent_app_type] => 1
[patent_app_number] => 8/009423
[patent_app_country] => US
[patent_app_date] => 1993-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4228
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/270/06270988.pdf
[firstpage_image] =>[orig_patent_app_number] => 009423
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/009423 | Process for producing recombinant proteins using a gene for tRNA | Jan 26, 1993 | Issued |
Array
(
[id] => 3802414
[patent_doc_number] => 05830643
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Partially double-stranded oligonucleotide and method for forming oligonucleotide'
[patent_app_type] => 1
[patent_app_number] => 7/974303
[patent_app_country] => US
[patent_app_date] => 1992-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 21780
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 326
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/830/05830643.pdf
[firstpage_image] =>[orig_patent_app_number] => 974303
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/974303 | Partially double-stranded oligonucleotide and method for forming oligonucleotide | Nov 9, 1992 | Issued |
Array
(
[id] => 4002165
[patent_doc_number] => 06004805
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-21
[patent_title] => 'Transcriptional enhancer from milk protein genes'
[patent_app_type] => 1
[patent_app_number] => 7/891541
[patent_app_country] => US
[patent_app_date] => 1992-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6751
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/004/06004805.pdf
[firstpage_image] =>[orig_patent_app_number] => 891541
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/891541 | Transcriptional enhancer from milk protein genes | May 28, 1992 | Issued |
Array
(
[id] => 1594988
[patent_doc_number] => 06492137
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Response element compositions and assays employing same'
[patent_app_type] => B1
[patent_app_number] => 07/672530
[patent_app_country] => US
[patent_app_date] => 1991-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 12
[patent_no_of_words] => 10813
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492137.pdf
[firstpage_image] =>[orig_patent_app_number] => 07672530
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/672530 | Response element compositions and assays employing same | Mar 18, 1991 | Issued |